Table 3. The inhibitory activities against BaF3/TEL-AXL cell viability of six compounds.
| Cpds. | IC50 (nM) | |
|---|---|---|
| Axl kinase | BaF3/TEL-AXL proliferation | |
| w11 | 5 | 15.5 |
| w12 | 5 | 2.8 |
| w13 | 8 | 16.0 |
| w18 | 5 | 7.4 |
| w24 | 6 | 97.9 |
| Cpds. | IC50 (nM) | |
|---|---|---|
| Axl kinase | BaF3/TEL-AXL proliferation | |
| w11 | 5 | 15.5 |
| w12 | 5 | 2.8 |
| w13 | 8 | 16.0 |
| w18 | 5 | 7.4 |
| w24 | 6 | 97.9 |